Created at Source Raw Value Validated value
Feb. 25, 2022, noon oms

Patient above 18 yrs to 80 yrs of age <br/ > 2. Patients with diagnosed case of Autoimmune Rheumatic Disease <br/ > 3. Patients who are on stable doses of immunosuppressants for more than 3 months and on stable doses of more than 3 weeks in case of steroids <br/ > 4. Patients who are seronegative or suboptimal response after both doses of Covid 19 vaccine <br/ > 5. Patients who are willing to provide informed consent and to comprehend with the study

Patient above 18 yrs to 80 yrs of age <br/ > 2. Patients with diagnosed case of Autoimmune Rheumatic Disease <br/ > 3. Patients who are on stable doses of immunosuppressants for more than 3 months and on stable doses of more than 3 weeks in case of steroids <br/ > 4. Patients who are seronegative or suboptimal response after both doses of Covid 19 vaccine <br/ > 5. Patients who are willing to provide informed consent and to comprehend with the study